{"slideshow_credits": null, "snippet": "Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients\u2019 requests for lifesaving medicines before they are approved.", "abstract": "Giant drug maker Johnson & Johnson is tapping renowned bioethicist Arthur L Caplan to form panel to evaluate requests by critically ill patients for access to potentially lifesaving, experimental medicines prior to their approval; issue is fraught with emotion and raises basic ethical questions about fairness and equal access to care; move by Johnson & Johnson could prompt other drug makers to follow suit.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2015/05/07/business/company-creates-bioethics-panel-on-trial-drugs.html", "lead_paragraph": "Johnson & Johnson named the bioethicist Arthur L. Caplan to create a panel to decide on patients\u2019 requests for lifesaving medicines before they are approved.", "headline": {"main": "Company Creates Bioethics Panel on Trial Drugs", "print_headline": "Company Creates Panel for Access to Trial Drugs"}, "_id": "554ae38d38f0d85a64346934", "word_count": "1668", "multimedia": [{"height": 126, "url": "images/2015/05/07/business/Ethics/Ethics-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/05/07/business/Ethics/Ethics-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 936, "url": "images/2015/05/07/business/Ethics/Ethics-articleLarge.jpg", "legacy": {"xlarge": "images/2015/05/07/business/Ethics/Ethics-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "936"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/05/07/business/Ethics/Ethics-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/05/07/business/Ethics/Ethics-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-05-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Johnson & Johnson", "is_major": "Y", "rank": "1"}, {"name": "persons", "value": "Caplan, Arthur L", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "New York University Langone Medical Center", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Merck & Company Inc", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Chimerix Inc", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Ethics and Official Misconduct", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}